http://www.biovalley.com/ The Life Sciences Network Newsfeed en-us BioValley the Trinational Network Wed, 01, Feb 2012 15:10:53 +0100 http://www.biovalley.com/rssfeed.cfm?nid=18916 Glioblastomas are regarded as particularly aggressive brain tumors. Wed, 01, Feb 2012 18916 http://www.biovalley.com/rssfeed.cfm?nid=18915 Basel - Novartis announced that following a priority review, the US Food and Drug Administration has approved an update to the Glivec label to recommend 36 months of treatment after surgery for adult patients with KIT (CD117)-positive gastrointestinal stromal tumors who met the risk of recurrence inclusion criteria of the pivotal trial. Wed, 01, Feb 2012 18915 http://www.biovalley.com/rssfeed.cfm?nid=18914 "Lilly's fourth quarter results not only reflect the impact of recent patent expirations, but also highlight the growth opportunities that will enable us to remain a strong and successful company in the years ahead," Wed, 01, Feb 2012 18914 http://www.biovalley.com/rssfeed.cfm?nid=18913 Roche announced that it has provided notice to Illumina, Inc. that it will nominate a slate of highly qualified, independent candidates for election to Illumina’s Board of Directors and propose certain other matters for the consideration of Illumina’s shareholders at Illumina’s 2012 annual meeting, which, if adopted, would result in Roche-nominated directors comprising a majority of the Illumina board. Wed, 01, Feb 2012 18913 http://www.biovalley.com/rssfeed.cfm?nid=18912 LUDWIGSHAFEN, Germany - The value of the BASF Crop Protection pipeline increased by €400 million to €2.8 billion. Growth was mainly driven by the company’s star fungicide F 500, which is expected to exceed peak sales of €1 billion. Wed, 01, Feb 2012 18912 http://www.biovalley.com/rssfeed.cfm?nid=18911 DUBLIN, Ohio - Cardinal Health announced the availability of its Smart-Seal surgical mask, designed to enhance fit and help reduce fog on eyewear. Wed, 01, Feb 2012 18911 http://www.biovalley.com/rssfeed.cfm?nid=18910 Roche CEO Severin Schwan commenting on the Group’s 2011 results: “We achieved our sales and earnings targets for the year and also made significant progress with our pipeline. Wed, 01, Feb 2012 18910 http://www.biovalley.com/rssfeed.cfm?nid=18909 ST. LOUIS - Sigma-Aldrich Corporation announced it has completed its acquisition of BioReliance Holdings, Inc. from Avista Capital Partners for $350 million in cash, subject to normal post-closing adjustments. Wed, 01, Feb 2012 18909 http://www.biovalley.com/rssfeed.cfm?nid=18908 Insilico Biotechnology is one of the partners in atransnational EU-project out to find a common, easy-to-use computer-based platform for modeling metabolic processes in organisms which are of interest for biotechnological applications. Tue, 31, Jan 2012 18908 http://www.biovalley.com/rssfeed.cfm?nid=18907 Silicone is flexible, biocompatible and heat-resistant, characteristics that make organosilicone compounds ideal for a wide range of applications in medical technology. Up until now, the broad application of such compounds has been hampered chiefly by the high surface friction of silicone. Tue, 31, Jan 2012 18907 http://www.biovalley.com/rssfeed.cfm?nid=18906 Roche, a leader in research-focused healthcare with combined strengths in pharmaceuticals, life science tools and diagnostics, announced that it has commenced a cash tender offer to acquire all outstanding shares of Illumina, Inc. Tue, 31, Jan 2012 18906 http://www.biovalley.com/rssfeed.cfm?nid=18905 RIDGEFIELD, Conn., and INDIANAPOLIS - Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company announced the U.S. Food and Drug Administration has approved Jentadueto tablets, Tue, 31, Jan 2012 18905 http://www.biovalley.com/rssfeed.cfm?nid=18904 Roche announced that Erivedge (vismodegib) capsule was approved by the U.S. Food and Drug Administration for adults with a type of skin cancer, called basal cell carcinoma, that has spread to other parts of the body or that has come back after surgery or that their healthcare provider decides cannot be treated with surgery or radiation. Tue, 31, Jan 2012 18904 http://www.biovalley.com/rssfeed.cfm?nid=18903 Hopewell Township, NJ and Waukesha, WI - Capital Health and GE Healthcare announced the first Discovery NM 750b was installed at Capital Health’s New Jersey Hopewell medical center. Tue, 31, Jan 2012 18903 http://www.biovalley.com/rssfeed.cfm?nid=18902 DUBLIN, Ohio - Cardinal Health and Cook Medical announced a two-year, exclusive agreement for the North American distribution of Cook Medical central venous catheter sets with Cardinal Health Presource customizable procedural kits - providing clinicians with advanced technology the flexibility of customization for their vascular access needs. Tue, 31, Jan 2012 18902 http://www.biovalley.com/rssfeed.cfm?nid=18901 Microsoft and General Electric, which last month announced plans to form a new health-care technology company, have filed a series of trademark applications for the word “Caradigm” - laying claim to the name for a wide range of health-care products and services. Tue, 31, Jan 2012 18901 http://www.biovalley.com/rssfeed.cfm?nid=18900 Paris, France - Sanofi announced a new partnership with the Bill & Melinda Gates Foundation and Eisai to join the World Health Organization’s existing Global Programme to Eliminate Lymphatic Filariasis in 2020, and further commitments to the World Health Organization to eliminate Human African Trypanosomiasis, also known as sleeping sickness, by 2020. Mon, 30, Jan 2012 18900 http://www.biovalley.com/rssfeed.cfm?nid=18899 Davos/Monheim - The private sector is committed to play a strong role in transforming agriculture to address urgent global needs, said Sandra Peterson, Chief Executive Officer of Bayer CropScience, at the World Economic Forum in Davos, Switzerland. Mon, 30, Jan 2012 18899 http://www.biovalley.com/rssfeed.cfm?nid=18898 GE Healthcare, Chalfont St Giles, UK - GE Healthcare’s Discovery CT750 HD, the world’s first high-definition CT system, has been included in the first fully positive recommendation from the National Institute for Health and Clinical Excellence’s Diagnostic Assessment Programme which aims to ensure the National Health Service can rapidly and consistently adopt clinically and cost effective technologies. Mon, 30, Jan 2012 18898 http://www.biovalley.com/rssfeed.cfm?nid=18897 Monheim - Bayer CropScience is pleased to announce that it has received registration from the U.S. Environmental Protection Agency for its TwinLink technology for cotton in the USA. Mon, 30, Jan 2012 18897